Abstract

N-arachidonoyl glycine (NAGly) is an endogenous lipid deriving from the endocannabinoid anandamide (AEA). Identified as a ligand of several G-protein coupled receptors (GPCRs), it can however exert biological responses independently of GPCRs. NAGly was recently shown to depress store-operated Ca2+ entry (SOCE) but its mechanism of action remains elusive. The major aim of this study was to gain a better knowledge on the NAGly-dependent impairment of SOCE in neurons of the central nervous system (CNS) from mice. First, we examined the expression of genes encoding for putative lipid sensing GPCRs using transcriptomic data publicly available. This analysis showed that the most abundant GPCRs transcripts present in the cerebral cortices of embryonic brains were coding for lysophosphatidic acid (LPA) and sphingosine-1 phosphate (S1P) receptors. Next, the presence of functional receptors was assessed with live-cell calcium imaging experiments. In primary cortical cells S1P and LPA mobilize Ca2+ from internal stores via a mechanism sensitive to the S1P and LPA receptor antagonists Ex26, H2L5186303, or Ki16425. However, none of these compounds prevented or attenuated the NAGly-dependent impairment of SOCE. We found no evidence for the requirement of lipid sensing GPCRs in this inhibitory process, indicating that NAGly is an endogenous modulator interfering with the core machinery of SOCE. Moreover, these data also raise the intriguing possibility that the depression of SOCE could play a role in the central effects of NAGly.

Highlights

  • N-arachidonoyl glycine (NAGly) is a lipid deriving from the endocannabinoid anandamide (AEA)

  • In order to determine whether NAGly is acting via a G-protein coupled receptors (GPCRs), we analyzed the expression of genes encoding for putative lipid sensing GPCRs in the embryonic cerebral cortex

  • The most abundant transcripts were coding for cannabinoid receptors type 1 (CB1) (Cnr[1] gene), the orphan receptor GPR12, lysophosphatidic acid (LPA) and sphingosine-1 phosphate (S1P) receptors (Fig. 1)

Read more

Summary

Introduction

N-arachidonoyl glycine (NAGly) is a lipid deriving from the endocannabinoid anandamide (AEA) It is naturally present in various tissues and organs like the brain[1,2] but the physiological functions exerted by NAGly in the neural system are not yet fully characterized. This endogenous bioactive molecule influences pain perception and displays analgesic properties[1,3,4,5]. The aim of the present work was to verify whether a lipid sensing GPCR is contributing to the NAGly-induced impairment of SOCE in cortical neurons. After having checked the presence of functional receptors, the contribution of LPA and S1P receptors to the NAGly-dependent inhibition of SOCE was evaluated using a pharmacological approach

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.